While overseas investors gave India the cold shoulder in 2024, domestic institutions demonstrated remarkable resilience, maintaining strong inflows. In October, when Indian markets saw the largest foreign institutional investor (FII) sell-off of the year at ₹91,933.64 crore, domestic institutional investors (DIIs) stepped in with the highest monthly net purchases of ₹1,05,253.33 crore.
In fact, 2024 was the fourth consecutive year when DIIs poured more money into markets than FIIs, showed a 2 January IIFL Securities report. Though FIIs returned as net buyers in December, it may be too soon to assume the trend will continue throughout 2025.
"The significant FII selling in the last quarter of 2024 suggests caution, likely driven by a mix of global macroeconomic factors and domestic concerns," according to the research team of Bajaj Broking (Bajaj Financial Securities).
The continuation of this trend in 2025 will depend on how the global economy performs, the actions of the Indian government and the Reserve Bank of India (RBI), and corporate earnings. If global interest rates remain high or inflationary pressures persist, FIIs might continue to favour developed markets, it added.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Art, music, food and winter chill
A Mint guide to what's happening in and around your city
Alcohol-free booze options abound for dry January
A tilt towards healthier lifestyles around the world has stirred the demand for non-alcoholic drinks
Repeat your outfits to go with anti-algorithm style
There is an old-school charm to repeating clothes, and for fashion to be truly sustainable, it is all the more essential
A Boycott of Costco for Its DEI Efforts Is Not Likely to Succeed
The US retailer has a loyal base of shoppers that it's unlikely to lose
Wealth tax: Let's judge it by principles of taxation
Tax canons laid down by Adam Smith remain relevant, though his list has been extended. Test the idea of a wealth tax against these, lest we get carried away by progressive idealism
Hacked in 2024? India's privacy rules require you to take action
Draft digital personal data protection rules demand that data breaches be reported retrospectively
Cutting Through the Clutter: Key Focus Areas for Retail Investors in 2025
Remember that social media is for fun, and not serious topics such as personal finance advice
MFD, RIA, RA: Explore your career as a financial adviser
Understand the earning potential, licensing and compliance to choose your best suited path
Health insurance claims: How to ensure grievance redressal
My health insurer recently rejected my claim, citing my inability to provide key internal hospital papers that they require. Despite having submitted all other necessary documents, they are insisting on these specific papers, which I am unable to obtain from the hospital. I believe my claim is valid and that I have complied with all the necessary documentation required. What are my options to ensure that my grievance is handled fairly and my claim is reconsidered? -Name withheld on request
Eli Lilly to Set Up GCC in Hyderabad
Pharma major Eli Lilly and Co. on Thursday said it plans to establish a new global capability centre (GCC) in Hyderabad and hire over 1,000 people to strengthen its digital strategy and service delivery.
